ENDRA Life Sciences Inc. (NDRA) stock
NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$4.04+0.12 (+2.93%)
Close on Nov 18, 2026Market cap $6.05MP/E –Yield –
ENDRA Life Sciences gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
ENDRA Life Sciences's gross profit for the twelve months ending Dec 31, 2019 was $0, down 100.0% year over year. For fiscal 2020 it was $0. The highest annual figure on record is $279.70K in fiscal 2016.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $0 | – |
| FY2019 | Dec 31, 2019 | $0 | -100.0% |
| FY2018 | Dec 31, 2018 | $6.17K | -96.5% |
| FY2017 | Dec 31, 2017 | $178.84K | -36.1% |
| FY2016 | Dec 31, 2016 | $279.70K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | – |
| Q2 FY2019 | Jun 30, 2019 | $0 | – |
| Q1 FY2019 | Mar 31, 2019 | $0 | -100.0% |
| Q4 FY2018 | Dec 31, 2018 | $0 | -100.0% |
| Q3 FY2018 | Sep 30, 2018 | $0 | -100.0% |
| Q2 FY2018 | Jun 30, 2018 | $0 | -100.0% |
| Q1 FY2018 | Mar 31, 2018 | $6.17K | – |
| Q4 FY2017 | Dec 31, 2017 | $3.77K | -98.7% |
| Q3 FY2017 | Sep 30, 2017 | $168.73K | – |
| Q2 FY2017 | Jun 30, 2017 | $6.35K | – |
| Q1 FY2017 | Mar 31, 2017 | $0 | – |
| Q4 FY2016 | Dec 31, 2016 | $279.70K | – |
| Q3 FY2016 | Sep 30, 2016 | $0 | – |
See a number that looks wrong?